| 수집원 | 발생값 ↓ | 관측 가능 시각 | 법인 | 회사명 | 사업연도 | 기간 | 연결구분 | 재무제표 | 계정명 | 표준 지표 | 금액 | 기준일 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| dart-financials | 2025-08-14 | 2026-07-23 20:12:16 | — | 케이티 | 2,025 | H1 | OFS | IS | 당기순이익(손실) | net_income | 3580.6억원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:16 | — | 케이티 | 2,025 | H1 | OFS | IS | 총포괄손익 | comprehensive_income | 5124.3억원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:16 | — | 케이티 | 2,025 | H1 | OFS | IS | 영업비용 | — | 4.3조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:11:59 | — | 삼성SDI | 2,025 | H1 | OFS | IS | 매출액 | revenue | 2.7조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:11:59 | — | 삼성SDI | 2,025 | H1 | OFS | IS | 영업이익 | operating_income | -6399.1억원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:11:59 | — | 삼성SDI | 2,025 | H1 | OFS | IS | 법인세차감전 순이익 | pretax_income | -6585.4억원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:11:59 | — | 삼성SDI | 2,025 | H1 | OFS | IS | 당기순이익(손실) | net_income | -4337.6억원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:11:59 | — | 삼성SDI | 2,025 | H1 | OFS | IS | 총포괄손익 | comprehensive_income | -3764.1억원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:00 | — | LG화학 | 2,025 | H1 | CFS | BS | 유동자산 | current_assets | 27조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:00 | — | LG화학 | 2,025 | H1 | CFS | BS | 비유동자산 | non_current_assets | 66.9조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:00 | — | LG화학 | 2,025 | H1 | CFS | BS | 자산총계 | total_assets | 93.9조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:00 | — | LG화학 | 2,025 | H1 | CFS | BS | 유동부채 | current_liabilities | 21.6조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:00 | — | LG화학 | 2,025 | H1 | CFS | BS | 비유동부채 | non_current_liabilities | 27.7조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:00 | — | LG화학 | 2,025 | H1 | CFS | BS | 부채총계 | total_liabilities | 49.3조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:00 | — | LG화학 | 2,025 | H1 | CFS | BS | 자본금 | capital_stock | 3914억원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:00 | — | LG화학 | 2,025 | H1 | CFS | BS | 이익잉여금 | retained_earnings | 17.9조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:00 | — | LG화학 | 2,025 | H1 | CFS | BS | 자본총계 | total_equity | 44.5조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:00 | — | LG화학 | 2,025 | H1 | CFS | IS | 매출액 | revenue | 11.4조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:00 | — | LG화학 | 2,025 | H1 | CFS | IS | 영업이익 | operating_income | 4767.8억원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:00 | — | LG화학 | 2,025 | H1 | CFS | IS | 법인세차감전 순이익 | pretax_income | -1847.7억원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:00 | — | LG화학 | 2,025 | H1 | CFS | IS | 당기순이익(손실) | net_income | -1118.8억원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:00 | — | LG화학 | 2,025 | H1 | CFS | IS | 총포괄손익 | comprehensive_income | -2.4조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:00 | — | LG화학 | 2,025 | H1 | OFS | BS | 유동자산 | current_assets | 7.9조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:11:54 | — | 삼성전자 | 2,025 | H1 | CFS | BS | 자본금 | capital_stock | 8975.1억원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:11:54 | — | 삼성전자 | 2,025 | H1 | CFS | BS | 부채총계 | total_liabilities | 105.3조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:00 | — | LG화학 | 2,025 | H1 | OFS | BS | 비유동자산 | non_current_assets | 25조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:00 | — | LG화학 | 2,025 | H1 | OFS | BS | 자산총계 | total_assets | 32.9조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:17 | — | SK텔레콤 | 2,025 | H1 | CFS | BS | 자본금 | capital_stock | 304.9억원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:00 | — | LG화학 | 2,025 | H1 | OFS | BS | 유동부채 | current_liabilities | 6.7조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:00 | — | LG화학 | 2,025 | H1 | OFS | BS | 비유동부채 | non_current_liabilities | 5.5조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:00 | — | LG화학 | 2,025 | H1 | OFS | BS | 부채총계 | total_liabilities | 12.3조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:00 | — | LG화학 | 2,025 | H1 | OFS | BS | 자본금 | capital_stock | 3914억원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:00 | — | LG화학 | 2,025 | H1 | OFS | BS | 이익잉여금 | retained_earnings | 17.4조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | OFS | IS | 매출액 | revenue | 1조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | OFS | BS | 자본총계 | total_equity | 9.9조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | OFS | BS | 이익잉여금 | retained_earnings | 4.1조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | OFS | BS | 자본금 | capital_stock | 1779.3억원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | OFS | BS | 부채총계 | total_liabilities | 3.6조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | OFS | BS | 비유동부채 | non_current_liabilities | 1.3조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | OFS | BS | 유동부채 | current_liabilities | 2.2조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | OFS | BS | 자산총계 | total_assets | 13.5조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | OFS | BS | 비유동자산 | non_current_assets | 9.7조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | OFS | BS | 유동자산 | current_assets | 3.8조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | CFS | IS | 총포괄손익 | comprehensive_income | 3226.8억원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | CFS | IS | 당기순이익(손실) | net_income | 3243.8억원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | CFS | IS | 법인세차감전 순이익 | pretax_income | 4089억원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | CFS | IS | 영업이익 | operating_income | 4755.9억원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | CFS | IS | 매출액 | revenue | 1.2조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | CFS | BS | 자본총계 | total_equity | 11.6조원 | 2025-06-30 |
| dart-financials | 2025-08-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | H1 | CFS | BS | 이익잉여금 | retained_earnings | 5.7조원 | 2025-06-30 |